We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Updated Guidance on Developing Pulmonary Tuberculosis Drugs
FDA Issues Updated Guidance on Developing Pulmonary Tuberculosis Drugs
The FDA says a single, well-controlled trial may be used to support a drug candidate for treatment of pulmonary tuberculosis (TB) if additional confirmatory evidence is available, in a revised draft guidance released yesterday.